AzTrials
AzTrials

Data QualityNCT05144230

Healthy Data: Improving Health Information Quality Using Intelligent Systems

An observational study of Data Quality, run by University of Portsmouth.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Electronic Health Record Systems (EHR) play an integral role in healthcare practice, enabling health organisations to collect, access and manage data more consistently. There is also a great deal of interest in using EHR data to improve decision-making and accelerate medical interventions. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Data Quality
How many people
60,000 participants
Where
No sites listed yet
Study dates
Feb 2022to Apr 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Patient records captured by Portsmouth Hospitals University National Health Service Trust (PHU) between 01/01/2020 and 31/12/2020

Who may be able to join

  • No specific exclusion criteria

Who cannot join

  • No specific exclusion criteria

Trial locations and contacts

No sites are listed yet.

Obinwa Ozonze, MSc contact

07391566946

obinwa.ozonze@port.ac.uk

Adrian Hopgood, PhD contact

02392842946

adrian.hopgood@port.ac.uk

About this study

Official title: Collection of Electronic Health Records (EHR) for Validation of Artificial Intelligence Based Tool for Data Quality Assessment

Electronic Health Record Systems (EHR) play an integral role in healthcare practice, enabling health organisations to collect, access and manage data more consistently. There is also a great deal of interest in using EHR data to improve decision-making and accelerate medical interventions. However, like all information systems, they are prone to data quality problems such as incomplete records, values outside normal ranges and implausible relationships. These problems are expected to become more prevalent as more organisations adopt electronic health record systems, aggregate, share and explore health data. The investigators believe current efforts to improve health data quality can be made more effective if backed by appropriate technology in the form of a readily accessible intelligent tool. Building on this, the investigators developed an Artificial Intelligence (AI) tool for automating data quality assessment of health data. In this study, the investigators evaluate the AI tool using a real-world dataset.

Read the detailed description

The main aim of this study is to assess the reliability and utility of an AI tool in identifying data quality dimensions of interest for secondary use of health data, including completeness, conformance and plausibility. In assessing this tool, this study will retrospectively analyse data captured during routine clinical care and identify records containing listed data quality dimensions. This study will also assess the consistency of the AI tool in generating and executing data quality checks.

Conditions
Data Quality

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Data quality dimensions prevalence

    The number of patient records identified by the AI tool with completeness, conformance and plausibility violations

    Measured: 12 months, between 01/01/2020 and 31/12/2020

  2. Consistency of AI tool

    Consistency of AI tool in generating measures for detecting data quality dimensions

    Measured: 2 months, through study completion

  3. Validity of AI tool detection

    Validity of data quality dimensions identified by the AI tool

    Measured: 2 months, through study completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2021
  2. Study startFeb 2022 (estimated)
  3. Primary completionApr 2022 (estimated)
  4. Study completionApr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
60,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05144230
Sponsor's protocol ID
UP717295
Status last verified
Dec 2021
First submitted
21 Nov 2021
Last updated
22 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, Estiri H, Goerg C, Holve E, Johnson SG, Liaw ST, Hamilton-Lopez M, Meeker D, Ong TC, Ryan P, Shang N, Weiskopf NG, Weng C, Zozus MN, Schilling L. A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data. EGEMS (Wash DC). 2016 Sep 11;4(1):1244. doi: 10.13063/2327-9214.1244. eCollection 2016.

    PubMed 27713905

Questions about this trial

What is this clinical trial studying?

An observational study of Data Quality, run by University of Portsmouth.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Obinwa Ozonze, MSc (07391566946, obinwa.ozonze@port.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Data quality dimensions prevalence (time frame: 12 months, between 01/01/2020 and 31/12/2020). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05144230, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in